Article Correctness Is Author's Responsibility: Erenumab as a Therapy for Hard to Treat Episodic Migraine

The article below may contain offensive and/or incorrect content.

Erenumab 140 mg is a well-tolerated and potentially effective preventive treatment for patients with episodic migraine, according to a phase 3b study.